Skip to content

Effect of Erector Spinae Muscle Block with Bupivacaine on Postoperative Pain Following Lumbar Surgery

Effectiveness of erector spinae muscle block with direct visualization injection of 0.25% bupivacaine at the end of lumbar surgery on postoperative pain: a randomized clinical trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20251216068353N1
Enrollment
90
Registered
2026-02-06
Start date
2026-01-21
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative lumbar pain (lumbar laminectomy). Other acute postprocedural pain

Interventions

Intervention 1: Intervention GroupIn: patients assigned to the intervention group, at the end of lumbar laminectomy surgery after complete completion of all surgical steps, achievement of adequate hem

Sponsors

Babol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age between 18 and 65 years. Candidate for elective lumbar laminectomy surgery at a maximum of two levels between L1 and L5. Provision of written informed consent to participate in the study. No use of any analgesic medication within 48 hours before surgery. No history of rheumatologic or musculoskeletal disorders. No known allergy to bupivacaine or anesthetic drugs. Body mass index less than or equal to 45.

Exclusion criteria

Exclusion criteria: Inability to understand or reliably report pain intensity using the Visual Analog Scale (VAS) Presence of neurological disorders that affect pain perception, sensation, or motor function Presence of active infection, inflammation, or skin lesion at the planned erector spinae block injection site Documented coagulation disorders or use of anticoagulant medications that contraindicate regional anesthesia blocks Presence of severe and unstable systemic diseases that make regional analgesia unsafe

Design outcomes

Primary

MeasureTime frame
Severity of postoperative pain measured using the Visual Analog Scale (VAS) during the first 24 hours after surgery. Timepoint: Postoperative pain severity will be measured using the Visual Analog Scale (VAS) after the intervention, immediately in the recovery period following the end of surgery, and subsequently at 2, 6, 12, and 24 hours after completion of lumbar surgery. Method of measurement: Pain intensity is measured using the Visual Analogue Scale for pain assessment, in which zero represents no pain and ten represents the worst imaginable pain. All assessments are performed by a trained evaluator blinded to group allocation.

Secondary

MeasureTime frame
Time to first administration of intravenous analgesic after completion of lumbar surgery. Timepoint: From the end of surgery until administration of the first intravenous analgesic within the first 24 hours postoperatively. Method of measurement: Recording the time of first intravenous analgesic administration according to nursing and medication records.;Length of hospital stay after completion of lumbar surgery. Timepoint: From the completion of lumbar surgery until hospital discharge. Method of measurement: Calculation of hospital stay based on recorded admission and discharge dates and times in medical records.;Level of functional disability in activities of daily living during the first week after hospital discharge. Timepoint: One week after hospital discharge. Method of measurement: Assessment of functional disability using the Quebec Functional Disability Scale questionnaire, which evaluates daily activity performance.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMeisam Ghorbanpoor

Babol University of Medical Sciences

M.ghorbanpour@mubabol.ac.ir+98 11 3219 7667

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026